Co-Authors
This is a "connection" page, showing publications co-authored by Lieuwe Bos and Peter Bonta.
Connection Strength
0.116
-
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. Lancet Respir Med. 2021 09; 9(9):957-968.
Score: 0.059
-
Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia. Thromb Res. 2020 12; 196:135-137.
Score: 0.056